Significats de risk ratio en anglès

Crucial in the development of novel biological agents, however, is the benefit: risk ratio.

To define the benefit- risk ratio, six prospective randomized trials are currently in progress.

The secondary outcome was the risk ratio for treatment discontinuation.

Pooled risk ratio or standardized mean differences were calculated; HT adverse reactions were descriptively evaluated.

Questions remain concerning quality of life and benefit-to- risk ratio with respect to immunotherapy in individual patients.

The proportions receiving VCT and the adjusted risk ratio (adj.

Excellent safety, tolerability, and comfort profile supports this new CsA formulation as having a positive benefit-to- risk ratio.

The relation between the risk ratio observed in an epidemiological study and the per-exposure cofactor effect was investigated.

The risk ratio for evaluating pain scores, the need for rescue analgesia and all adverse effects were assessed.

Familial aggregation and inter-relationships of these traits were examined by recurrence risk ratio, heritability, genetic and environmental correlations.

The benefit- risk ratio favors anticoagulant therapy.

We used a random-effect model to calculate the mean difference or risk ratio with the 95% CI.

The programme-related risk ratio in 1987-1991 indicated a significant 20% beneficial effect.

Data were pooled and reported as hazard ratio (HR) or risk ratio (RR) under a random-effects model.

Random-effects meta-analysis was conducted to synthesize risk ratio (RR) and 95% confidence interval (CI) for each endpoint.

Standardized mean difference will be used to synthesize continuous variables and risk ratio will be used to synthesize categorical variables.